Pay in 4 interest-free payments of $6.32 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Common side effects (from clinical trial data): Nausea affects roughly 44% of users Diarrhea 30% Vomiting 24% Constipation 24% Abdominal pain 20% These are the main reasons most people stop taking these drugs
Additionally, studies have indicated that GLP-1RAs may directly stimulate acinar cells, leading to increased pancreatic enzyme levels and a potential pathway for the development of pancreatitis 14,15
Any spending drops these consumers have reverse after six months, so they go back to their old shopping habits
The Risks of Dehydration on GLP-1 Medications While feeling thirsty is annoying, the underlying dehydration can lead to more serious health concerns if ignored
Americas Poison Centers reported a nearly 1,500% increase in calls related to GLP-1s since 2019
Strategic FMCG & Retail Growth Leader FMCG & Retail Strategist | General Trade & Omni-Channel Growth | Driving Consumer & Channel Performance | Retail Execution | GT-Focused Insights Indias GLP-1 Market Just Got More Competitive - And More Accessible Abbotts partnership with Novo Nordisk to launch Extensor (semaglutide) as a second Ozempic brand in India signals a pivotal shift in the diabetes and obesity therapeutics landscape
US$ 27.49
US$ 26.78
-the-right-way-seo-graphics-gs.png?sfvrsn=5784682_3)
US$ 25.70
